Cargando…
Does androgen deprivation therapy protect against severe complications from COVID-19?
Autores principales: | Patel, V.G., Zhong, X., Liaw, B., Tremblay, D., Tsao, C.-K., Galsky, M.D., Oh, W.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347319/ https://www.ncbi.nlm.nih.gov/pubmed/32653425 http://dx.doi.org/10.1016/j.annonc.2020.06.023 |
Ejemplares similares
-
Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer
por: Shevach, Jeffrey, et al.
Publicado: (2015) -
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022) -
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
por: Shah, Neil J, et al.
Publicado: (2022) -
Lacrimal sac adenocarcinoma managed with androgen deprivation
por: Abramson, David H., et al.
Publicado: (2020) -
Protective Effects of KH-204 in the Bladder of Androgen-Deprived Rats
por: Bae, Woong Jin, et al.
Publicado: (2015)